Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold—if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
William Blair Starts Agile Therapeutics (AGRX) at Outperform
June 17, 2014 9:24 AM EDTWilliam Blair initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with an Outperform rating.
For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.
Shares of Agile Therapeutics closed at $6.78 yesterday.
... MoreJanney Starts Agile Therapeutics (AGRX) at Buy
June 17, 2014 7:23 AM EDTJanney Montgomery Scott initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.
Shares of Agile Therapeutics closed at $6.78 yesterday.
... More
